Abstract
Glucagon is critically underutilized, and we explored whether this is due to inadequate glucagon prescribing or the patient's inability to fill prescriptions. Of 216 commercially insured, high-risk individuals with diabetes who were prescribed glucagon in our healthcare system, 142 (65.4%) had a claim indicating its fill within 30 days.
Original language | English (US) |
---|---|
Article number | 110720 |
Journal | Diabetes Research and Clinical Practice |
Volume | 200 |
DOIs | |
State | Published - Jun 2023 |
Keywords
- Diabetes
- Glucagon
- Hypoglycemia
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Endocrinology